Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Historical diagnostic failure, not conceptual collapse: A response to Frith.
(2026 Sep 29)
Psychol Med 56(): e305
Doherty M, Henderson J, Hill H, Rabenstein K, Lang J, Grosjean B, Dakin C, Wijetilleka S, Shaw SCK

Is Active Surveillance Safe for Low-Risk Papillary Thyroid Cancer?
(2026 Sep 28)
Laryngoscope
Jones H, O'Keeffe N, Lennon P, Kinsella J, Fitzgerald CW, Shaha AR

Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment.
(2026 Sep 28)
Nat Genet
Baeten JT, Chan ICC, Moukarzel L, Petrone GEM, Liu J, Tran D, Tabs J, Tabet I, Agashe S, Nasrollahzadeh E, Vasireddy A, Carter A, Patel M, Stopsack KH, Kantoff PW, Zhou W, Batchi-Bouyou AL, Beeler JS, Mustion G, Pharoah P, Brenton J, Offit K, Barnett E, Li B, Abida W, Schram AM, Weigelt B, Mutch D, Vindigni A, Mullen M, Cruchaga C, Scher H, Levine R, Papaemmanuil E, Machiela MJ, Cadoo K, Link DC, Bolton KL

Which R(2) should be used to benchmark polygenic score performance against heritability?
(2026 Sep 28)
J Hum Genet
Kelly CM

A Trojan horse story: does pyroptosis open the gates to its own inhibition?
(2026 Sep 29)
Cell Res
Henry ÓC, O'Neill LAJ

Show complete publication list

In the News